Watch | COVID-19 Bulletin: India's First Vaccine Candidate Gets Regulatory Nod for Human Trials

Name: Watch | COVID-19 Bulletin: Indias First Vaccine Candidate Gets Regulatory Nod for Human Trials - The Wire
Uploaded: 2020-06-30T10:45:04+05:30
Channel: The Wire
Description: Hyderabad-based vaccine manufacturer, Bharat Biotech, has been accorded permission by the Drug Controller General of India (DCGI) to initiate Phase I & II human clinical trials.

Hyderabad-based vaccine manufacturer, Bharat Biotech, has been accorded permission by the Drug Controller General of India (DCGI) to initiate Phase I & II human clinical trials.

Pawanjot Kaur

Hyderabad-based vaccine manufacturer, Bharat Biotech, has been accorded permission by the Drug Controller General of India (DCGI) to initiate Phase I & II human clinical trials.

watch covid 19 bulletin india s first vaccine candidate gets regulatory nod for human trials

According to media reports, the Hyderabad-based vaccine manufacturer, Bharat Biotech, has been accorded permission by the Drug Controller General of India (DCGI) to initiate Phase I & II human clinical trials for India's first vaccine candidate against COVID-19.

The vaccine has been named Covaxin and is an inactivated vaccine developed indigenously. It was developed after the National Institute of Virology, Pune isolated a strain of the SARS-CoV-2 and transferred it to the company. Human clinical trials are scheduled to start across India in July 2020.

This article went live on June thirtieth, two thousand twenty, at forty-five minutes past ten in the morning.

The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.